Can lamotrigine and hydroxyzine cause xerostomia?

Can Lamotrigine or Hydroxyzine Cause Dry Mouth?

Yes, both lamotrigine and hydroxyzine can cause dry mouth (xerostomia), though hydroxyzine is far more likely to produce this side effect due to its anticholinergic properties, while lamotrigine's association with dry mouth is documented but less prominent.

Hydroxyzine and Xerostomia

Hydroxyzine is a first-generation antihistamine with significant anticholinergic effects that directly cause dry mouth 1. The FDA drug label does not explicitly list xerostomia as a common adverse effect, but the mechanism is well-established through its anticholinergic activity 2.

Evidence for Hydroxyzine-Induced Dry Mouth

• First-generation antihistamines, including hydroxyzine, commonly produce anticholinergic effects such as dryness of mouth and eyes 1.
• Hydroxyzine is specifically listed among first-generation antihistamines (diphenhydramine, hydroxyzine, clemastine) that cause anticholinergic side effects, with dry mouth being a characteristic manifestation 1.
• In patients with mast cell activation syndrome, first-generation H1R antihistamines like hydroxyzine are noted to cause cognitive decline, particularly in elderly patients, due to their anticholinergic effects 1.
• Hydroxyzine appears in comprehensive medication reviews as a xerogenic drug, with an 80% sedation rate and documented anticholinergic properties 1.

Clinical Considerations for Hydroxyzine

• Elderly patients are more susceptible to anticholinergic effects from hydroxyzine, including dry mouth, and face increased risk for complications 1.
• The anticholinergic burden increases when hydroxyzine is combined with other medications that have similar properties 1.
• Hydroxyzine should be used with caution in patients with pre-existing conditions that may be worsened by anticholinergic effects, such as benign prostatic hypertrophy or elevated intraocular pressure 1.

Lamotrigine and Xerostomia

Lamotrigine's association with dry mouth is documented in medication databases and systematic reviews, though it is not prominently featured in clinical guidelines as a primary xerogenic agent.

Evidence for Lamotrigine-Induced Dry Mouth

• Lamotrigine appears in comprehensive systematic reviews of medications inducing salivary gland dysfunction and xerostomia 3.
• Multiple databases of adverse event notifications have documented dry mouth as a reported side effect of lamotrigine 4.
• A reference guide to drugs and dry mouth includes lamotrigine among xerogenic medications, though the mechanism differs from anticholinergic agents 5.

Mechanism and Clinical Context

• Unlike hydroxyzine, lamotrigine does not work through anticholinergic mechanisms, suggesting an alternative pathway for inducing dry mouth 1.
• Lamotrigine is used for conditions such as trigeminal neuralgia and short unilateral neuralgiform pain with autonomic features (SUNA/SUNCT), where dry mouth may be part of the underlying condition rather than solely a medication effect 1.
• The incidence and severity of lamotrigine-induced xerostomia appear to be lower compared to medications with strong anticholinergic properties 3.

Comparative Risk Assessment

Hydroxyzine poses a substantially higher risk for dry mouth than lamotrigine due to its direct anticholinergic mechanism 1. The risk is further amplified by:

• Polypharmacy, particularly when combined with other anticholinergic medications 6, 7.
• Advanced age, with elderly patients showing greater susceptibility to anticholinergic side effects 1, 8.
• Pre-existing conditions affecting salivary function, such as Sjögren's syndrome or diabetes 8.

Management Strategies

For Hydroxyzine-Induced Xerostomia

• Consider substituting with a second-generation antihistamine (cetirizine, fexofenadine, loratadine) that lacks anticholinergic properties 1.
• If hydroxyzine cannot be discontinued, implement supportive measures including oral lubricants, saliva substitutes containing xylitol, and good oral hygiene practices 6.
• Avoid combining hydroxyzine with other anticholinergic medications to reduce cumulative anticholinergic burden 7.

For Lamotrigine-Induced Xerostomia

• Assess whether dry mouth is truly medication-related or part of the underlying neurological condition being treated 1.
• Implement supportive care with topical products containing olive oil, betaine, and xylitol, or artificial saliva 1.
• Consider prescription cholinergic agonists if xerostomia is severe and confirmed to be medication-related 6.

General Interventions

• Maintain adequate hydration, as fluid intake restrictions compound medication-induced dry mouth 8.
• Use frozen gauze pads with normal saline or ice, which have been shown to reduce oral dryness 1.
• Implement regular oral hygiene methods to prevent dental caries and periodontal disease, which are increased risks with chronic xerostomia 6.

Important Caveats

• Subjective sensation of dry mouth does not always correlate with objectively measured salivary flow rates; measurement of unstimulated salivary flow should be performed before initiating treatment 8.
• Xerostomia treatment can improve symptoms in approximately 75% of patients receiving xerogenic medications, potentially preventing medication discontinuation 7.
• In elderly patients with multiple medications, conducting a comprehensive medication review to identify and minimize anticholinergic burden is essential 6, 7.